Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy

Abstract Background To compare the one-year outcomes between intravitreal brolucizumab (IVBr) monotherapy and photodynamic therapy (PDT) as a second-line treatment in patients with polypoidal choroidal vasculopathy (PCV) who did not respond to first-line therapy. Methods This case–control study incl...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ryoh Funatsu, Hiroto Terasaki, Naohisa Mihara, Shozo Sonoda, Hideki Shiihara, Taiji Sakamoto
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2024-04-01
Reeks:	International Journal of Retina and Vitreous
Onderwerpen:	Polypoidal choroidal vasculopathy Photodynamic therapy Brolucizumab Neovascular age-related macular degeneration
Online toegang:	https://doi.org/10.1186/s40942-024-00553-5
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!